Concanavalin A target cells in human brain tumours

Area of Science:

• Neuro-oncology
• Histopathology
• Biochemistry

Background:

• Central nervous system (CNS) tumors exhibit diverse cellular morphologies.
• Understanding cellular markers is crucial for accurate diagnosis and classification of brain neoplasms.

Purpose of the Study:

• To investigate the binding patterns of Concanavalin A (Con A) in various human brain tumors.
• To determine if Con A binding is specific to tumor histology or cell type (cytotypical vs. histotypical).
• To assess the potential of Con A lectin mapping as a diagnostic tool for CNS tumors.

Main Methods:

• Analysis of 143 formalin-fixed paraffin-embedded biopsy specimens from common CNS tumors.
• Application of the lectin-peroxidase method to detect Concanavalin A binding.
• Examination of binding patterns in oligodendrogliomas, astrocytomas, glioblastomas, ependymomas, neurinomas, meningiomas, medulloblastomas, and plexus papillomas.

Main Results:

• Con A binding varied significantly across different tumor types and cell morphologies.
• Oligodendrogliomas showed weak intracytoplasmic staining; astrocytomas displayed strong reactions in fibrillary astrocytes.
• Plexus papillomas and xanthomatous meningiomas exhibited strong intracytoplasmic Con A staining, while medulloblastomas were negative.
• Con A binding patterns were found to be cytotypical rather than histotypical, correlating with differentiation grade.

Conclusions:

• Concanavalin A binding in human brain tumors is cell-type specific, offering cytotypical patterns.
• Lectin mapping with Con A can potentially aid in the differential diagnosis of CNS neoplasms.
• The density of Con A acceptors appears related to the tumor's grade of differentiation.